Intuitive Surgical (ISRG) Expected to Announce Earnings on Tuesday

Intuitive Surgical (NASDAQ:ISRGGet Free Report) is projected to post its Q3 2025 results after the market closes on Tuesday, October 21st. Analysts expect Intuitive Surgical to post earnings of $2.00 per share and revenue of $2.4075 billion for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, October 21, 2025 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.78 earnings per share. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $446.13 on Friday. The firm has a market capitalization of $159.93 billion, a PE ratio of 62.22, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The business’s fifty day moving average price is $454.97 and its 200 day moving average price is $495.75. Intuitive Surgical has a 12 month low of $425.00 and a 12 month high of $616.00.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating on the stock in a report on Wednesday. Evercore ISI dropped their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a report on Tuesday, October 7th. UBS Group set a $529.00 price objective on shares of Intuitive Surgical in a research note on Monday, October 13th. Finally, Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $580.29.

Check Out Our Latest Analysis on Intuitive Surgical

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently made changes to their positions in the business. Riggs Asset Managment Co. Inc. boosted its stake in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 32 shares during the period. Osterweis Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $200,000. Darwin Wealth Management LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $218,000. Security National Bank of SO Dak acquired a new stake in Intuitive Surgical in the second quarter valued at about $220,000. Finally, Blue Chip Partners LLC acquired a new stake in Intuitive Surgical in the second quarter valued at about $237,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Earnings History for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.